Expandable List
Infectious diseases account for millions of deaths worldwide each year and incur tremendous health care costs. The McMaster Antimicrobial Research Centre (ARC) seeks to provide excellence in research and innovation in the areas of basic and applied health science that impact positively on the causes, control and amelioration of infectious diseases. Expertise in the group spans the disciplines of Chemistry, Biochemistry, Molecular Microbiology, Clinical Microbiology, Drug Discovery and Infectious Disease Medicine and researchers in the group have interests in virology, bacteriology and the biochemistry of fungi. The vision of the ARC is to establish and maintain national and internationally competitive research in the broad field of infectious disease. This web site serves as a portal to this research and informs on the activities and interests of the group.
Infectious diseases account for millions of deaths worldwide each year and incur tremendous health care costs. The McMaster Antimicrobial Research Centre (ARC) seeks to provide excellence in research and innovation in the areas of basic and applied health science that impact positively on the causes, control and amelioration of infectious diseases. Expertise in the group spans the disciplines of Chemistry, Biochemistry, Molecular Microbiology, Clinical Microbiology, Drug Discovery and Infectious Disease Medicine and researchers in the group have interests in virology, bacteriology and the biochemistry of fungi. The vision of the ARC is to establish and maintain national and internationally competitive research in the broad field of infectious disease. This web site serves as a portal to this research and informs on the activities and interests of the group.
The Centre for Emerging Device Technologies (CEDT) is an organization that facilitates study of the optical, electrical, mechanical, and biological properties of semiconductors and related materials and promotes the development of technology based on these materials.
The Centre for Minimal Access Surgery, located at St. Joseph’s Healthcare in Hamilton, Ontario, has successfully trained over 9,000 surgeons, fellows and residents in the last 15 years. CMAS continues to provide quality and value in our state-of-the-art, multi-disciplinary, technological education and research centre.
The Juravinski Cancer Centre operates on a philosophy that combines high quality, evidence-based treatment, compassionate care, education and research. Researchers at the JCC, in partnership with McMaster University, are international leaders in this field, making significant contributions to the growing body of knowledge about cancer treatment and control around the world. As an academic health sciences centre, the JCC is actively involved in educating and mentoring the next generation of physicians, health professionals and researchers.Through the Escarpment Cancer Research Institute (ECRI) – a joint HHS and McMaster University research institute, cancer research is also conducted in the core areas of translational research, clinical trials, and quality of health care/knowledge translation by multidisciplinary teams.
The McMaster Institute of Applied Radiation Sciences (McIARS) exists to promote interdisciplinary research. In particular, to promote research in radiation science and engineering applied to biology, medicine and industry. McIARS aims to be a meeting point of industry, government and academia centred at a research intensive university.
The McMaster Manufacturing Research Institute (MMRI) opened for business in May 2001. The MMRI is one of the largest university based manufacturing research institutes in Canada, supporting academic research and education programs spanning many manufacturing processes. The institute’s core focus is on enhancing productivity, quality and product/process innovation while helping companies reduce cost.
The Henderson Research Centre was established in 1988 as a joint initiative of the Hamilton Civic Hospitals (now part of the Hamilton Health Sciences) and McMaster University. In 2010, it moved to the David Braley Research Institute and was renamed the Thrombosis and Atherosclerosis Research Institute. Its mission is “to reduce death and disability from thrombotic diseases by conducting research into the pathogenesis, prevention, diagnosis and treatment of thrombosis and vascular disease”